Schedule 13G ownership disclosure

TITAN PHARMACEUTICALS INC DE

Security class unavailable · CUSIP: 888314606

Event date: 2021-01-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
681,250
Percent of class
6.9100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-000390
Form type
SC 13G
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 21, 2021
Reporting period
Jan 15, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub